Literature DB >> 10742150

The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.

P Liu1, K Aitken, Y Y Kong, M A Opavsky, T Martino, F Dawood, W H Wen, I Kozieradzki, K Bachmaier, D Straus, T W Mak, J M Penninger.   

Abstract

Infections are thought to be important in the pathogenesis of many heart diseases. Coxsackievirus B3 (CVB3) has been linked to chronic dilated cardiomyopathy, a common cause of progressive heart disease, heart failure and sudden death. We show here that the sarcoma (Src) family kinase Lck (p56lck) is required for efficient CVB3 replication in T-cell lines and for viral replication and persistence in vivo. Whereas infection of wild-type mice with human pathogenic CVB3 caused acute and very severe myocarditis, meningitis, hepatitis, pancreatitis and dilated cardiomyopathy, mice lacking the p56lck gene were completely protected from CVB3-induced acute pathogenicity and chronic heart disease. These data identify a previously unknown function of Src family kinases and indicate that p56lck is the essential host factor that controls the replication and pathogenicity of CVB3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742150     DOI: 10.1038/74689

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  41 in total

Review 1.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling.

Authors:  Fabienne Rehren; Barbara Ritter; Oliver Dittrich-Breiholz; Andreas Henke; Elena Lam; Semra Kati; Michael Kracht; Albert Heim
Journal:  Med Microbiol Immunol       Date:  2012-06-03       Impact factor: 3.402

Review 3.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22.

Authors:  Matthias Nestler; Ulrike Martin; Peter Hortschansky; Hans-Peter Saluz; Andreas Henke; Thomas Munder
Journal:  Mol Cell Biochem       Date:  2006-05-09       Impact factor: 3.396

5.  Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Honglin Luo; Bobby Yanagawa; Jingchun Zhang; Zongshu Luo; Mary Zhang; Mitra Esfandiarei; Christopher Carthy; Janet E Wilson; Decheng Yang; Bruce M McManus
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.

Authors:  Chandana Koorella; Jayakumar R Nair; Megan E Murray; Louise M Carlson; Stephanie K Watkins; Kelvin P Lee
Journal:  J Biol Chem       Date:  2014-01-10       Impact factor: 5.157

7.  Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  K S Choi; H S Jun; H N Kim; H J Park; Y W Eom; H L Noh; H Kwon; H M Kim; J W Yoon
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.

Authors:  Xiaoning Si; Honglin Luo; Andrew Morgan; Jingchun Zhang; Jerry Wong; Ji Yuan; Mitra Esfandiarei; Guang Gao; Caroline Cheung; Bruce M McManus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility.

Authors:  S A Huber; M Rincon
Journal:  Virology       Date:  2008-09-30       Impact factor: 3.616

10.  Transgenic mouse model for echovirus myocarditis and paralysis.

Authors:  Scott A Hughes; Harshwardhan M Thaker; Vincent R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.